Receptor protein that binds to a growth factor protein
Agrowth factor receptor is areceptor that binds to agrowth factor .[ 1] Growth factor receptors are the first stop in cells where the signaling cascade for cell differentiation and proliferation begins. Growth factors, which areligands that bind to the receptor are the initial step to activating the growth factor receptors and tells the cell to grow and/or divide.
These receptors may use theJAK/STAT ,MAP kinase , andPI3 kinase pathways.[ 2]
A majority of growth factor receptors consists ofreceptor tyrosine kinases (RTKs) . There are 3 dominant receptor types that are exclusive to research : theepidermal growth factor receptor , theneurotrophin receptor , and theinsulin receptors .[ 3] All growth factor receptors are membrane bound and composed of 3 general protein domains:extracellular ,transmembrane , andcytoplasmic .[ 4] The extracellular domain region is where aligand may bind, usually with very high specificity.[ 5] InRTKs , the binding of a ligand to the extracellular ligand binding site leads to theautophosphorylation of tyrosine residues in the intracellular domain.[ 6] These phosphorylations allow for other intracellular proteins to bind to with thephosphotyrosine-binding domain which results in a series of physiological responses within the cell.[ 6]
Research in today's society focus on growth factor receptors in order to pinpoint cancer treatment.Epidermal growth factor receptors are involved heavily with oncogene activity.[ 7] Once growth factors bind to their receptor, a signal transduction pathway occurs within the cell to ensure the cell is working. However, in cancerous cells, the pathway might never turn on or turn off.[ 7] Furthermore, in certain cancers, receptors (such asRTKs ) are often observed to beoverexpressed , which corresponds to the uncontrolled proliferation and differentiation of cells.[ 8] For this same reason, tyrosine receptors are often a target forcancer therapy.[ 8]
^ Growth+Factor+Receptors at the U.S. National Library of MedicineMedical Subject Headings (MeSH)^ A. V. Hoffbrand; P. A. H. Moss; J. E. Pettit (2006).Essential haematology . Wiley-Blackwell. pp. 6–.ISBN 978-1-4051-3649-5 . Retrieved28 November 2010 . ^ McInnes, Campbell; Sykes, Brian D. (1997). "Growth factor receptors: Structure, mechanism, and drug discovery".Peptide Science .43 (5):339– 366.doi :10.1002/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W .ISSN 1097-0282 .PMID 9566117 . ^ Goodman, Steven R., ed. (2008-01-01),"Chapter 7 - Intercellular Signaling" ,Medical Cell Biology (Third Edition) , Academic Press, pp. 227– 248,doi :10.1016/B978-0-12-370458-0.50012-8 ,ISBN 978-0-12-370458-0 , retrieved2020-04-29 ^ Kouvidi, Katerina; Nikitovic, Dragana; Berdiaki, Aikaterini; Tzanakakis, George N. (2014-01-01), Simpson, Melanie A.; Heldin, Paraskevi (eds.),"Chapter Twelve - Hyaluronan/RHAMM Interactions in Mesenchymal Tumor Pathogenesis: Role of Growth Factors" ,Advances in Cancer Research , Hyaluronan Signaling and Turnover,123 , Academic Press:319– 349,doi :10.1016/B978-0-12-800092-2.00012-5 ,PMID 25081535 , retrieved2020-04-29 ^a b Trenker, Raphael; Jura, Natalia (2020-04-01)."Receptor tyrosine kinase activation: From the ligand perspective" .Current Opinion in Cell Biology .63 :174– 185.doi :10.1016/j.ceb.2020.01.016 .ISSN 0955-0674 .PMC 7813211 .PMID 32114309 . ^a b Sasaki, Takamitsu; Hiroki, Kuniyasu; Yamashita, Yuichi (2013)."The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment" .BioMed Research International .2013 546318.doi :10.1155/2013/546318 .ISSN 2314-6133 .PMC 3748428 .PMID 23986907 . ^a b Bennasroune, Amar; Gardin, Anne; Aunis, Dominique; Crémel, Gérard; Hubert, Pierre (2004-04-01)."Tyrosine kinase receptors as attractive targets of cancer therapy" .Critical Reviews in Oncology/Hematology .50 (1):23– 38.doi :10.1016/j.critrevonc.2003.08.004 .ISSN 1040-8428 .PMID 15094157 .
Angiopoietin CNTF EGF (ErbB)
FGF
FGFR1 FGFR2 Agonists: Ersofermin FGF (1 ,2 (bFGF) ,3 ,4 ,5 ,6 ,7 (KGF ),8 ,9 ,10 (KGF2) ,17 ,18 ,22 )Palifermin Repifermin Selpercatinib Sprifermin Trafermin FGFR3 FGFR4 Unsorted
HGF (c-Met) IGF
LNGF (p75NTR ) PDGF RET (GFL)
SCF (c-Kit) TGFβ Trk
TrkA Negative allosteric modulators: VM-902A TrkB Agonists: 3,7-DHF 3,7,8,2'-THF 4'-DMA-7,8-DHF 7,3'-DHF 7,8-DHF 7,8,2'-THF 7,8,3'-THF Amitriptyline BDNF BNN-20 Deoxygedunin Deprenyl Diosmetin DMAQ-B1 HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 R13 TDP6 TrkC
VEGF Others Additional growth factors: Adrenomedullin Colony-stimulating factors (seehere instead)Connective tissue growth factor (CTGF) Ephrins (A1 ,A2 ,A3 ,A4 ,A5 ,B1 ,B2 ,B3 )Erythropoietin (seehere instead)Glucose-6-phosphate isomerase (GPI; PGI, PHI, AMF) Glia maturation factor (GMF) Hepatoma-derived growth factor (HDGF) Interleukins /T-cell growth factors (seehere instead)Leukemia inhibitory factor (LIF) Macrophage-stimulating protein (MSP; HLP, HGFLP) Midkine (NEGF2) Migration-stimulating factor (MSF; PRG4) Oncomodulin Pituitary adenylate cyclase-activating peptide (PACAP) Pleiotrophin Renalase Thrombopoietin (seehere instead)Wnt signaling proteins Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)